These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36011376)

  • 1. Genetics of Pediatric Epilepsy: Next-Generation Sequencing in Clinical Practice.
    Blazekovic A; Gotovac Jercic K; Meglaj S; Duranovic V; Prpic I; Lozic B; Malenica M; Markovic S; Lujic L; Petelin Gadze Z; Juraski RG; Barišic N; Baric I; Borovecki F
    Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the best candidates for next-generation sequencing-based gene panel for evaluation of early-onset epilepsy.
    Lee J; Lee C; Ki CS; Lee J
    Mol Genet Genomic Med; 2020 Sep; 8(9):e1376. PubMed ID: 32613771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Customised targeted massively parallel sequencing enables more precise diagnosis of patients with epilepsy.
    Atli EI; Atli E; Yalcintepe S; Demir S; Kalkan R; Eker D; Gurkan H
    Intern Med J; 2022 Jul; 52(7):1174-1184. PubMed ID: 33528079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact on Clinical Decision Making of Next-Generation Sequencing in Pediatric Epilepsy in a Tertiary Epilepsy Referral Center.
    Hoelz H; Herdl C; Gerstl L; Tacke M; Vill K; von Stuelpnagel C; Rost I; Hoertnagel K; Abicht A; Hollizeck S; Larsen LHG; Borggraefe I
    Clin EEG Neurosci; 2020 Jan; 51(1):61-69. PubMed ID: 31554424
    [No Abstract]   [Full Text] [Related]  

  • 5. High Diagnostic Yield and Clinical Utility of Next-Generation Sequencing in Children with Epilepsy and Neurodevelopmental Delays: A Retrospective Study.
    Charouf D; Miller D; Haddad L; White FA; Boustany RM; Obeid M
    Int J Mol Sci; 2024 Sep; 25(17):. PubMed ID: 39273593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next-generation sequencing in childhood-onset epilepsies: Diagnostic yield and impact on neuronal ceroid lipofuscinosis type 2 (CLN2) disease diagnosis.
    Gall K; Izzo E; Seppälä EH; Alakurtti K; Koskinen L; Saarinen I; Singh A; Myllykangas S; Koskenvuo J; Alastalo TP
    PLoS One; 2021; 16(9):e0255933. PubMed ID: 34469436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-generation sequencing in pediatric-onset epilepsies: Analysis with target panels and personalized therapeutic approach.
    Castellotti B; Ragona F; Freri E; Messina G; Magri S; Previtali R; Solazzi R; Franceschetti S; Taroni F; Canafoglia L; Gellera C; Granata T; DiFrancesco JC
    Epilepsia Open; 2024 Oct; 9(5):1922-1930. PubMed ID: 39215763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-generation sequencing in children with epilepsy: The importance of precise genotype-phenotype correlation.
    Horák O; Burešová M; Kolář S; Španělová K; Jeřábková B; Gaillyová R; Česká K; Réblová K; Šoukalová J; Zídková J; Fajkusová L; Ošlejšková H; Rektor I; Danhofer P
    Epilepsy Behav; 2022 Mar; 128():108564. PubMed ID: 35065395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic testing and counseling: The contribution of next-generation sequencing to epilepsy genetics.
    Alsubaie L; Aloraini T; Amoudi M; Swaid A; Eyiad W; Al Mutairi F; Ababneh F; Alrifai MT; Baarmah D; Altwaijri W; Alotaibi N; Harthi A; Rumayyan A; Alanazi A; Qrimli M; Alfadhel M; Alfares A
    Ann Hum Genet; 2020 Nov; 84(6):431-436. PubMed ID: 32533790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic outcomes for genetic testing of 70 genes in 8565 patients with epilepsy and neurodevelopmental disorders.
    Lindy AS; Stosser MB; Butler E; Downtain-Pickersgill C; Shanmugham A; Retterer K; Brandt T; Richard G; McKnight DA
    Epilepsia; 2018 May; 59(5):1062-1071. PubMed ID: 29655203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic yield of targeted massively parallel sequencing in children with epileptic encephalopathy.
    Kothur K; Holman K; Farnsworth E; Ho G; Lorentzos M; Troedson C; Gupta S; Webster R; Procopis PG; Menezes MP; Antony J; Ardern-Holmes S; Dale RC; Christodoulou J; Gill D; Bennetts B
    Seizure; 2018 Jul; 59():132-140. PubMed ID: 29852413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From next-generation sequencing to targeted treatment of non-acquired epilepsies.
    Møller RS; Hammer TB; Rubboli G; Lemke JR; Johannesen KM
    Expert Rev Mol Diagn; 2019 Mar; 19(3):217-228. PubMed ID: 30661434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broadening the scope of multigene panel analysis for adult epilepsy patients.
    Lee S; Kang MK; So KH; Jang R; Shin YW; Jang SS; Yoon JG; Kim S; Kim M; Chu K; Lee SK; Kim KJ; Baek ST; Lim BC; Moon J
    Epilepsia Open; 2024 Aug; 9(4):1538-1549. PubMed ID: 38946282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Next generation sequencing in children with unexplained epilepsy: A retrospective cohort study.
    Chen W; Qin J; Shen Y; Liang J; Cui Y; Zhang Y
    Brain Dev; 2021 Nov; 43(10):1004-1012. PubMed ID: 34120799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient strategy for the molecular diagnosis of intractable early-onset epilepsy using targeted gene sequencing.
    Rim JH; Kim SH; Hwang IS; Kwon SS; Kim J; Kim HW; Cho MJ; Ko A; Youn SE; Kim J; Lee YM; Chung HJ; Lee JS; Kim HD; Choi JR; Lee ST; Kang HC
    BMC Med Genomics; 2018 Feb; 11(1):6. PubMed ID: 29390993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy and developmental disorders: Next generation sequencing in the clinic.
    Symonds JD; McTague A
    Eur J Paediatr Neurol; 2020 Jan; 24():15-23. PubMed ID: 31882278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic Yield of Epilepsy Panels in Children With Medication-Refractory Epilepsy.
    Segal E; Pedro H; Valdez-Gonzalez K; Parisotto S; Gliksman F; Thompson S; Sabri J; Fertig E
    Pediatr Neurol; 2016 Nov; 64():66-71. PubMed ID: 27726903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective genotype-phenotype analysis in a 305 patient cohort referred for testing of a targeted epilepsy panel.
    Hesse AN; Bevilacqua J; Shankar K; Reddi HV
    Epilepsy Res; 2018 Aug; 144():53-61. PubMed ID: 29778030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of a 377 gene custom next-generation sequencing epilepsy panel.
    Bevilacqua J; Hesse A; Cormier B; Davey J; Patel D; Shankar K; Reddi HV
    J Genet; 2017 Sep; 96(4):681-685. PubMed ID: 28947717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epilepsy syndromes, etiologies, and the use of next-generation sequencing in epilepsy presenting in the first 2 years of life: A population-based study.
    Stödberg T; Tomson T; Barbaro M; Stranneheim H; Anderlid BM; Carlsson S; Åmark P; Wedell A
    Epilepsia; 2020 Nov; 61(11):2486-2499. PubMed ID: 32964447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.